Acne

Ranbaxy is launching its isotretinoin product for the treatment of acne, Absorica, in the United States.

Low-dose isotretinoin may be effective, with fewer side effects, when used to treat adult acne, results of a clinical trial presented at the annual congress of the European Academy of Dermatology and Venereology suggest.

A new study involving cross-sectional samples of the U.S. population reveals no association between isotretinoin and suicidality, the study-s author says.